In a filing, NovoCure Ltd revealed its Chief Financial Officer Brackmann Christoph acquired Company’s shares for reported $0.23 million on Jul 29 ’25. In the deal valued at $11.59 per share,20,000 shares were bought. As a result of this transaction, Brackmann Christoph now holds 141,150 shares worth roughly $1.61 million.
Then, Stafford Kristin sold 999 shares, generating $17,259 in total proceeds. Upon selling the shares at $17.28, the Director now owns 3,054 shares.
Before that, LEUNG GABRIEL sold 999 shares. NovoCure Ltd shares valued at $17,297 were divested by the Director at a price of $17.31 per share. As a result of the transaction, LEUNG GABRIEL now holds 81,229 shares, worth roughly $0.93 million.
Wells Fargo downgraded its NovoCure Ltd [NVCR] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Evercore ISI also remained covering NVCR and has increased its forecast on December 02, 2024 with a “an Outperform” recommendation from previously “an In-line” rating. H.C. Wainwright revised its rating on October 16, 2024. It rated NVCR as “a Buy” which previously was an “a Neutral”.
Price Performance Review of NVCR
On Tuesday, NovoCure Ltd [NASDAQ:NVCR] saw its stock fall -2.81% to $11.43. Over the last five days, the stock has gained 0.48%. NovoCure Ltd shares have fallen nearly -46.59% since the year began. Nevertheless, the stocks have fallen -61.64% over the past one year.
How much short interest is there in NovoCure Ltd?
A steep rise in short interest was recorded in NovoCure Ltd stocks on 2025-07-15, dropping by 17371.0 shares to a total of 4.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.94 million shares. There was a decline of -0.35%, which implies that there is a negative sentiment for the stock.
